Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Thursday 02 April, 2020

Morgan Stanley&CoLLC

Rule 38.5 - ABBVIE INC.

RNS Number : 5691I
Morgan Stanley & Co. LLC
02 April 2020
 

 

  FORM 38.5

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)

 

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

 

1.  KEY INFORMATION

 Name of exempt market-maker

  Morgan Stanley & Co. LLC

 Company dealt in

  ABBVIE INC.

 Class of relevant security to which the dealings being disclosed relate (Note 1)

  US$0.01 COMMON STOCK

 Date of dealing

  01 APRIL 2020

 

 

2.  DEALINGS  (Note 2)

 

(a)  Purchases and sales

 Total number of relevant secuities accquired

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

   1,557,329

 76.1900 USD

 71.4200 USD

 

 Total number of relevant secuities disposed

 Highest price paid (Note 3)

 Lowest price paid (Note 3)

   1,797,475

 76.1900 USD

 71.4200 USD

 

 

(b)  Derivatives transactions (other than options transactions)

 

 Product name, e.g. CFD

 Nature of transaction

  (Note 4)

 Number of relevant securities

  (Note 5)

 Price per unit

 N/A

 N/A

 N/A

 N/A

 

 

(c)  Options transactions in respect of existing relevant securities

 

i)  Writing, selling, purchasing or varying

 

 Product name, eg call option

 Writing, selling, purchasing, varying etc

 Number of securities to which the option relates (Note 5)

 Exercise Price

 Type, e.g American, European etc

 Expiry Date

 Option money paid/received per unit (Note 3)

 CALL

 PURCHASE

 100

 90.0000

A

 21/08/2020

 1.4700 USD

 CALL

 SALE

 100

 80.0000

A

 21/08/2020

 4.7000 USD

 CALL

 PURCHASE

 100

 78.0000

A

 03/04/2020

 0.2700 USD

 PUT

 PURCHASE

 100

 55.0000

A

 17/04/2020

 0.5100 USD

 PUT

 PURCHASE

 100

 72.0000

A

 03/04/2020

 1.1700 USD

 CALL

 PURCHASE

 400

 90.0000

A

 20/11/2020

 2.2600 USD

 PUT

 PURCHASE

 700

 72.0000

A

 24/04/2020

 4.3500 USD

 CALL

 PURCHASE

 100

 75.0000

A

 19/06/2020

 4.5900 USD

 CALL

 PURCHASE

 100

 70.0000

A

 17/04/2020

 5.3000 USD

 PUT

 PURCHASE

 1,900

 65.0000

A

 15/01/2021

 7.7700 USD

 PUT

 PURCHASE

 100

 65.0000

A

 15/01/2021

 7.7700 USD

 PUT

 PURCHASE

 100

 65.0000

A

 15/01/2021

 7.9500 USD

 CALL

 SALE

 100

 105.0000

A

 19/06/2020

 0.1100 USD

 CALL

 SALE

 100

 95.0000

A

 15/05/2020

 0.2400 USD

 CALL

 SALE

 500

 76.0000

A

 03/04/2020

 0.4400 USD

 CALL

 SALE

 100

 76.0000

A

 03/04/2020

 0.4500 USD

 CALL

 SALE

 200

 76.0000

A

 03/04/2020

 0.4500 USD

 CALL

 SALE

 100

 75.0000

A

 03/04/2020

 0.7500 USD

 CALL

 SALE

 100

 81.0000

A

 17/04/2020

 0.8000 USD

 CALL

 SALE

 100

 75.0000

A

 03/04/2020

 0.8100 USD

 PUT

 SALE

 500

 70.0000

A

 03/04/2020

 0.8400 USD

 PUT

 SALE

 100

 70.0000

A

 03/04/2020

 0.8600 USD

 CALL

 SALE

 100

 82.5000

A

 15/05/2020

 1.2900 USD

 CALL

 SALE

 200

 80.0000

A

 15/05/2020

 1.7200 USD

 CALL

 SALE

 100

 90.0000

A

 15/01/2021

 2.5800 USD

 CALL

 SALE

 100

 77.5000

A

 15/05/2020

 2.6000 USD

 PUT

 SALE

 100

 65.0000

A

 15/05/2020

 2.6900 USD

 CALL

 SALE

 100

 73.0000

A

 09/04/2020

 2.8500 USD

 PUT

 SALE

 9,800

 75.0000

A

 03/04/2020

 3.2000 USD

 PUT

 SALE

 200

 75.0000

A

 03/04/2020

 3.2000 USD

 CALL

 SALE

 100

 72.5000

A

 17/04/2020

 3.6000 USD

 CALL

 SALE

 100

 70.0000

A

 03/04/2020

 3.7100 USD

 CALL

 SALE

 100

 70.0000

A

 03/04/2020

 3.7100 USD

 PUT

 SALE

 100

 72.5000

A

 17/04/2020

 4.3200 USD

 CALL

 SALE

 1,300

 70.0000

A

 18/09/2020

 9.0000 USD

 CALL

 SALE

 100

 70.0000

A

 15/01/2021

 9.9400 USD

 

(ii) Exercising

 

 Product name, eg call option

 Number of securities

 Exercise price per unit (Note 3)

 N/A

 N/A

 N/A 

 

 

3. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 Date of disclosure

 02 APRIL 2020

 Contact Name

Craig Horsley

 Telephone Number

+44(141) 245 7736

 Name of offeree/offeror with which connected

ABBVIE INC.

Nature of connection (Note 6)

Advisory

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISESSISUEESSEDL

a d v e r t i s e m e n t